Vimarsana
Biggest News Aggregation in the World

Page 19 - Syncona Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Syncona Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Syncona Ltd Today - Breaking & Trending Today

Acquisition set to take ocular therapies to patients - Vimarsana News

Acquisition set to take ocular therapies to patients

Gyroscope Therapeutics Holdings, a portfolio company of life sciences investment trust Syncona Ltd, has been acquired by Novartis for up to $1. Click to read more...

UK's FTSE 100 edges lower on Omicron fears, downbeat GDP data - Vimarsana News

UK's FTSE 100 edges lower on Omicron fears, downbeat GDP data

UK's FTSE 100 inched lower on Wednesday on mounting concerns over the impact of the Omicron coronavirus variant on economic recovery and weaker-than-expected quarterly growth data. The... | December 22, 2021

Novartis buys UK gene therapy firm Gyroscope for up to USD1.5 billion - Vimarsana News

Novartis buys UK gene therapy firm Gyroscope for up to USD1.5 billion

Novartis buys UK gene therapy firm Gyroscope for up to USD1.5 billion | Financial News

Source: lse.co.uk
Novartis buys UK's Gyroscope for $1.5 billion to get gene therapy for eye disease - Vimarsana News

Novartis buys UK's Gyroscope for $1.5 billion to get gene therapy for eye disease

Swiss drugmaker Novartis AG is buying Gyroscope Therapeutics for up to $1.5 billion, looking to bolster its gene therapy roster with the British firm's treatment for geographic atrophy, a leading...

Omicron Weighs on Already Struggling U.K. Economy - Vimarsana News

Omicron Weighs on Already Struggling U.K. Economy

Omicron Weighs on Already Struggling UK Economy 1002 GMT - Economic growth slowed and the U.K.'s current account deficit widened in the third quarter, showing that the economy was struggling to...